Viewing Study NCT03804866

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:44 PM
Ignite Modification Date: 2026-02-02 @ 1:17 PM
Study NCT ID: NCT03804866
Status: COMPLETED
Last Update Posted: 2019-01-15
First Post: 2018-10-03
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: NGR-hTNF in Combination With an Anthracycline in Platinum-resistant Ovarian Cancer (NGR018)
Sponsor: AGC Biologics S.p.A.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None NGR-hTNF View
None Pegylated liposomal doxorubicin View
None Doxorubicin View
None Platinum-resistant View
None Progression or recurrence Ovarian Cancer View
None Ovarian Cancer View
None Advanced or metastatic View